Mirum Pharmaceuticals, Inc. (MIRM) vs Travere Therapeutics, Inc. (TVTX)
Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc. are of similar size ($5.8B and $5.7B). Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 77.1% against 44.0%. Travere Therapeutics, Inc. has the higher net margin (−7.35% vs −139.2%) and the higher return on invested capital (−18.3% vs −173.0%). Across the 16 metrics below, Travere Therapeutics, Inc. leads on 13 and Mirum Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | MIRM | TVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 98.60% | 65.16% |
| Operating margin | (134.93%) | (6.84%) | 0.00% |
| Net margin | (139.18%) | (7.35%) | 0.00% |
| Free cash flow margin | (44.29%) | 2.56% | 0.00% |
| Return on equity | (702.97%) | (151.79%) | (57.72%) |
| Return on assets | (97.15%) | (6.42%) | (49.22%) |
| Return on invested capital | (172.96%) | (18.31%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack